Natural products [i.e. plant and fungal extracts and metabolites] have long served as pivotal resources in the discovery and development of novel ...

From a distribution perspective, the B2C channel holds around 42.5% of market revenue in 2025, emerging as the dominant route ...

Driven by a dual product strategy of "digestion + gynecology," Wedge Pharma has established differentiated market barriers and is gradually building a product matrix that spans the entire lifecycle of ...

Biphenomycins, natural products derived from bacteria, show excellent antimicrobial activity, but have long remained out of ...

FDA's new guidance clarifies promotional practices for biosimilars, ensuring accurate marketing and preventing misleading ...

From enzymes and lipid nanoparticles to large-scale process design, four global innovators redefine RNA-based medicine development and delivery.

aArtificial Intelligence in Medicine Program, Mass General Brigham, Harvard Medical School, Boston, MA, USA bDepartment of Radiation Oncology, Brigham and Women’s Hospital, Dana-Farber Cancer ...

ThirdLaw Molecular, Inc. has rebranded as Ladder Bio Inc., a move the company says better reflects its focus on developing a new class of therapeutics based on ...

Editor’s note: Gustavo Mamao is head of international business development at IdeeLab, Brazilian foremost CDMO in ag biologicals. The views expressed in this article are the author’s own and do not ...